Published in J Lab Clin Med on January 01, 1993
Aspirin resistance: A fact or a myth? Exp Clin Cardiol (2005) 0.75
Aspirin prophylaxis for the prevention of thrombosis: expectations and limitations. Thrombosis (2012) 0.75
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest (1980) 2.01
Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Asoc Med P R (1990) 1.79
Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion. Am J Pathol (1974) 1.59
Localization of platelet prostaglandin production in the platelet dense tubular system. Am J Pathol (1976) 1.40
Investigation of the release reaction in platelets exposed to phorbol myristate acetate. Am J Pathol (1974) 1.39
Effects of the lonophore A23187 on the blood platelets II. Influence on ultrastructure. Am J Pathol (1974) 1.27
Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med (1980) 1.23
Influence of epinephrine on the aggregation response of aspirin-treated platelets. Prostaglandins Med (1980) 1.18
Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am J Pathol (1975) 1.12
Measurement of ionized calcium in blood platelets with a new generation calcium indicator. Biochem Biophys Res Commun (1985) 1.07
An actin-binding protein in human platelets. Interactions with alpha-actinin on gelatin of actin and the influence of cytochalasin B. Am J Pathol (1978) 1.07
Use of plasma glow for surface-engineering biomolecules to enhance bloodcompatibility of Dacron and PTFE vascular prosthesis. Biomaterials (2000) 1.06
Labile aggregation stimulating substance (LASS): the factor from storage pool deficient platelets correcting defective aggregation and release of aspirin treated normal platelets. Br J Haematol (1975) 1.05
Influence of the ionophore A23187 on the plastic behavior of normal erythrocytes. Am J Pathol (1977) 1.03
Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Studies of the dose-response relationship and mechanism of action in dogs. Am J Pathol (1978) 1.03
Surface-activated bovine platelets do not spread, they unfold. Am J Pathol (1990) 0.99
Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions. Thromb Res (1986) 0.99
Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. Am J Pathol (1998) 0.99
Effects of a microtubule stabilizing agent on the response of platelets to vincristine. Blood (1982) 0.97
Recycling of platelet phosphorylation and cytoskeletal assembly. J Cell Biol (1984) 0.96
Influence of a microtubule stabilizing agent on platelet structural physiology. Am J Pathol (1983) 0.93
Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function. Biochem Biophys Res Commun (1983) 0.92
Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin. Arteriosclerosis (1983) 0.91
Arachidonate-induced platelet aggregation in the dog. Thromb Res (1979) 0.90
Epinephrine potentiation of arachidonate-induced aggregation of cyclooxygenase-deficient platelets. Am J Hematol (1981) 0.90
Antisterility and antivitamin K activity of d-alpha-tocopheryl hydroquinone in the vitamin E-deficient female rat. J Nutr (1975) 0.89
An improved method for the extraction of endogenous platelet serotonin. J Lab Clin Med (1976) 0.89
Human platelet activation by an alkylacetyl analogue of phosphatidylcholine. Biochim Biophys Acta (1982) 0.88
Interleukin 1 stimulates endothelial cell tissue factor production and expression by a prostaglandin-independent mechanism. Thromb Haemost (1986) 0.88
The influence of glutathione depleting agents on human platelet function. Thromb Res (1989) 0.87
The influence of reserpine and ethylenediaminetetraacetic acid (EDTA) on serotonin storage organelles of blood platelets. Am J Pathol (1977) 0.86
Platelet storage pool deficiency and prostaglandin synthesis in chronic granulocytic leukaemia. Br J Haematol (1978) 0.84
Modification of human platelet response to sodium arachidonate by membrane modulation. Prostaglandins Med (1981) 0.83
Effects of 2,2'-dipyridyl and related compounds on platelet prostaglandin synthesis and platelet function. Biochim Biophys Acta (1980) 0.83
Effect of agents that alter cyclic AMP on arachidonate-induced platelet aggregation in the dog. Blood (1980) 0.82
Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation. Artif Organs (1999) 0.82
5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours. J Microencapsul (2001) 0.82
Influence of the calcium-sensitive fluorophore, Quin 2, on platelet function. Blood (1986) 0.82
Influence of pH on the prostacyclin (PGI2) mediated inhibition of platelet function. Prostaglandins Med (1980) 0.82
Glutathione levels in human platelets display a circadian rhythm in vitro. Thromb Res (1985) 0.82
Platelet aggregation independent of ADP release or prostaglandin synthesis in patients with hermansky-Pudlak syndrome. Prostaglandins Med (1981) 0.81
Changes in pericardial calcification due to antiplatelet agents: in vitro studies. Artif Organs (1998) 0.81
Acute effects of amrinone on regional myocardial and systemic blood flow distribution in the dog. Can J Physiol Pharmacol (1982) 0.81
Action of guanosine 5'-[beta-thio]diphosphate on thrombin-induced activation and Ca2+ mobilization in saponin-permeabilized and intact human platelets. Biochem J (1988) 0.80
The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes. Prostaglandins Med (1980) 0.80
Thermosensitization by increasing intracellular acidity with amiloride and its analogs. Int J Radiat Oncol Biol Phys (1994) 0.80
Retention of glycoprotein Ib/IX receptors on external surfaces of thrombin-activated platelets in suspension. Blood (1995) 0.79
Low dose aspirin, platelet function and prostaglandin synthesis: influence of epinephrine and alpha adrenergic blockade. Prostaglandins Med (1981) 0.79
Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(epsilon-caprolactone) microspheres-controlled release studies. Drug Deliv (2001) 0.79
Inhibition of prostaglandin (PG) synthesis in sheep vesicular gland microsomes (SVGM) by nitroblue tetrazolium (NBT) and vitamin E (VE). Prostaglandins Med (1979) 0.79
Smoking and platelet labile aggregation stimulating substance (LASS) synthesizing activity. Thromb Res (1976) 0.79
Irreversible platelet aggregation does not depend on lipoxygenase metabolites. Biochem Biophys Res Commun (1985) 0.79
Role of arachidonic acid metabolism in human platelet activation and irreversible aggregation. Am J Hematol (1985) 0.79
Effect of Amrinone, a cardiotonic drug, on hemodynamics and platelet function. Prostaglandins Med (1981) 0.79
Phospholipase A2 activation in human neutrophils requires influx of extracellular Ca2+ and leukotriene B4. Am J Physiol (1995) 0.79
Effect of acetaminophen and salicylate on aspirin-induced inhibition of human platelet cyclo-oxygenase. Prostaglandins Leukot Med (1982) 0.79
Development of poly(Lactic acid)/chitosan co-matrix microspheres: controlled release of taxol-heparin for preventing restenosis. Drug Deliv (2001) 0.78
The influence of vitamin E quinone on platelet structure, function, and biochemistry. Blood (1980) 0.78
Functional platelets after storage in vitro for 15--21 days. Am J Pathol (1980) 0.78
Influence of esterase inhibitors on platelet aggregation and release induced by phorbol myristate acetate. Biochem Pharmacol (1975) 0.78
Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion. Am J Pathol (1977) 0.78
The role of iron in prostaglandin synthesis: ferrous iron mediated oxidation of arachidonic acid. Prostaglandins Med (1978) 0.78
Aspirin treatment reduces platelet resistance to deformation. Arteriosclerosis (1987) 0.77
Problem with aspirin as antithrombotic agent in coronary artery disease. Lancet (1988) 0.77
Disaggregation and reaggregation of 'irreversibly' aggregated platelets: a method for more complete evaluation of anti-platelet drugs. Agents Actions (1985) 0.77
Inhibition of platelet aggregation by novel triphenylethylene analogs. Thromb Res (1986) 0.77
Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium. Prostaglandins Med (1980) 0.77
Comparative pharmacology of cyclooxygenase inhibitors on platelet function. Prostaglandins Leukot Med (1985) 0.77
Tranylcypromine induced hypertension is not mediated by the inhibition of prostacyclin synthesis. Prostaglandins Med (1979) 0.77
Enteric-coated aspirin, platelet cyclooxygenase activity and function. Prostaglandins Leukot Med (1984) 0.77
Evaluation of heparin immobilized chitosan-PEG microbeads for charcoal encapsulation and endotoxin removal. Artif Cells Blood Substit Immobil Biotechnol (2000) 0.77
Rapid return of cyclo-oxygenase active platelets in dogs after a single oral dose of aspirin. Prostaglandins (1981) 0.76
Platelet function in adolescent idiopathic scoliosis. Spine (Phila Pa 1976) (1992) 0.76
Proceedings: Differences in platelet storage pool deficiency (SPD) of Hermansky Pudlak syndrome (HPS) and non-albinos (NA). Thromb Diath Haemorrh (1975) 0.76
Reduction of heme by lipid peroxides and its potential relevance to understanding control of cyclo-oxygenase activity. Prog Lipid Res (1981) 0.76
Inhibition of ferrous iron induced oxidation of arachidonic acid by indomethacin. Prostaglandins Med (1979) 0.76
Vessel wall arachidonate metabolism after angioplasty: possible mediators of postangioplasty vasospasm. Am J Cardiol (1983) 0.76
Platelet adhesion to novel phospholipid materials: modified phosphatidylcholine covalently immobilized to silica, polypropylene, and PTFE materials. J Biomed Mater Res (1996) 0.76
Differential sensitivity of regional vascular beds in the dog to low-dose prostacyclin infusion. Can J Physiol Pharmacol (1980) 0.76
Role of platelet adhesion and aggregation in thrombus formation. Thromb Haemost (1998) 0.75
Epinephrine and platelet function. J Lab Clin Med (1997) 0.75
Influx of extracellular calcium and agonist-coupling appear essential for the activation of thromboxane A2-dependent phospholipase A2 in human platelets. Prostaglandins Leukot Essent Fatty Acids (1995) 0.75
Aggregated-disaggregated, refractory platelets retain sensitivity to ristocetin. Thromb Res (1996) 0.75
Platelet adhesion and spreading on protein-coated surfaces: variations in behavior in washed cells, PRP, and whole blood. J Biomater Appl (1998) 0.75
Influence of cytochalasin B (CB) on GP Ib distribution after thrombin or TRAP and before surface activation. Platelets (1997) 0.75
The influence of metabolities on the assay of platelet serotonin. Thromb Res (1977) 0.75
Size reduction-induced chain breaking in Haldane-chain compounds SrNi<sub>2-<i>x</i></sub>Mg<sub><i>x</i></sub>V<sub>2</sub>O<sub>8</sub> (<i>x</i>=0 and 0.1). J Phys Condens Matter (2017) 0.75
Thrombin-induced inhibition of platelet agglutination by von Willebrand factor (vWF): reversal by ionized calcium. Platelets (1996) 0.75
Ferrous iron mediated oxidation of arachidonic acid: studies employing nitroblue tetrazolium (NBT). Prostaglandins Med (1978) 0.75
Disappearance of Ising nature in Ca3ZnMnO6 studied by high-field ESR. J Phys Condens Matter (2014) 0.75
Arachidonic acid peroxidation, prostaglandin synthesis and platelet function. Photochem Photobiol (1979) 0.75
1,3-Dioctanoylglycerol (1,3-DiC8) is as effective as 1,2-dioctanoylglycerol (1,2-DiC8) in priming phospholipase A2 activation in human platelets and neutrophils. Biochem Med Metab Biol (1994) 0.75
Vitamin E and platelets: cooperative interactions with nitroblue tetrazolium on inhibition of adhesion, aggregation and secretion. Am J Pediatr Hematol Oncol (1979) 0.75
Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor. Arch Biochem Biophys (1996) 0.75
Surface-immobilized biomolecules on albumin modified porcine pericardium for preventing thrombosis and calcification. Int J Artif Organs (1999) 0.75
Modifications in accessibility of membrane glycoproteins, binding of specific ligands and coagulation factor V during the activation of platelets in blood emerging from bleeding time wounds. Am J Hematol (1999) 0.75
Ultrastructural expression of P-selectin on surface activated platelets. Platelets (1996) 0.75
Simple method for the separation of monohydroxy fatty acid metabolites of arachidonate metabolism. J Chromatogr (1982) 0.75
Aflatoxin detection by high-speed liquid chromatography and mass spectrometry. J Chromatogr (1973) 0.75
Rapid separation of tumor-promoting agents, phorbol and phorbol myristate acetate (12-o-tetradecanoylphorbol-13-acetate) by high-pressure liquid chromatography. J Chromatogr (1974) 0.75